AGOURON PHARMACEUTICALS REPORTS SECOND QUARTER RESULTS
AGOURON PHARMACEUTICALS REPORTS SECOND QUARTER RESULTS SAN DIEGO, Jan. 31 /PRNewswire/ -- Agouron Pharmaceuticals Inc.
(NASDAQ-NMS: AGPH) today announced a net loss for the second quarter and six months ended Dec. 31, 1991 of $2,480,000, or $.40 per common share, and $4,587,000, or $.83 per share, respectively. The net loss recorded in each comparable period of the prior fiscal year was $1,612,000, or $.34 per share, and $3,200,000, or $.71 per share.
Agouron Pharmaceuticals Inc. is a pioneer and leader in a new technology for the rational design of novel synthetic drugs based upon the molecular structures of proteins which play key roles in human disease. Agouron is currently applying this technology to the design and development of drugs for treatment of cancer, AIDS and other serious diseases. AGOURON PHARMACEUTICALS INC. Summary Financial Information (Dollars in thousands except per share amounts) Three Months Ended Six Months Ended Dec. 31, Dec. 31, 1991 1990 1991 1990 Revenues $1,477 $1,346 $2,573 $2,446 Net loss ($2,480) ($1,612) ($4,587) ($3,200) Net loss per common share ($.40) ($.34) ($.83) ($.71) Shares used in computing net loss per common share 6,207,000 4,736,500 5,544,000 4,490,900 -0- 1/31/92 /CONTACT: Steven S. Cowell, VP and CEO, or Donna Nichols of Agouron Pharmaceuticals, 619-622-3000/ (AGPH) CO: Agouron Pharmaceuticals ST: California IN: MTC ST: ERN
DM-EH -- SD002 -- 5800 01/31/92 17:00 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 31, 1992|
|Previous Article:||FIRST INTERSTATE BANK WELCOMES INDEPENDENCE BANK CUSTOMERS|
|Next Article:||CALIFORNIA DEPARTMENT OF AGING WELCOMES JAPANESE HEALTH CARE PROVIDERS|